Home

News

 

#BigDataforBloodCancer: Become involved in the HARMONY Alliance!
HARMONY Alliance sessions at the European LeukemiaNet Meeting
Joining forces to improve the treatment of myeloma: HARMONY participating in the second European Myeloma Network Meeting
HARMONY Alliance develops Core Outcome Sets for blood cancers. About Delphi Surveys.
End of year message
PRESS RELEASE: New data from HARMONY demonstrate the power of Big Data analytics to inform personalized medicine in blood cancer
HARMONY presents new results at the virtual 62nd Annual Meeting of the American Society of Hematology
HARMONY study maps uncertainties in clinical evidence that may impact market access for novel drugs in Hematologic Malignancies
Press Release: The HARMONY Alliance launches HARMONY PLUS, a new public-private partnership to improve outcomes for patients with blood cancers
IMI showcases HARMONY’s efforts in managing COVID-19
HARMONY-EHA webinar: The power of integrating harmonized AML patient data in hematology research
HARMONY Launched NHL Delphi Survey to Develop a Core Outcome Set for Non-Hodgkin Lymphoma
AML Hub interviews Professor Lars Bullinger, leader of HARMONY Work Package Definitions of Outcomes
Oncology Times publishes news feature on HARMONY
Where to find us at the 25th Annual Congress of EHA, virtual edition Virtual Edition.
HARMONY-EHA COVID-19 webinar: Integrating harmonized COVID-19 patient data
Press Release: HARMONY welcomes Pfizer as New Partner
We are all in this together!
A unified approach to leverage big data for blood cancer research
HARMONY Alliance newsletter: Latest updates in February 2020
Fact sheet: benefits of becoming an Associated Member
Mini-series on Big Data: three videos that explain it all
Highlights from BioData World 2019: successful collaboration of the IMI Big Data projects
Watch HARMONY’s journey toward enabling better and faster treatments for patients with Hematologic Malignancies
1-24   25-48   49-72   73-96   97-120   121-144   145-168   169-192   193-216   217-240